Healwell AI Future Growth
Future criteria checks 2/6
Healwell AI is forecast to grow earnings and revenue by 33.8% and 49.2% per annum respectively while EPS is expected to grow by 34.4% per annum.
Key information
33.8%
Earnings growth rate
34.4%
EPS growth rate
| Healthcare earnings growth | 27.6% |
| Revenue growth rate | 49.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 22 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 84 | -8 | -9 | 2 | 5 |
| 12/31/2025 | 71 | -20 | -12 | -3 | 8 |
| 12/31/2024 | 38 | -27 | -29 | -27 | 8 |
| 9/30/2024 | 26 | -20 | -26 | -24 | N/A |
| 6/30/2024 | 14 | -17 | -22 | -21 | N/A |
| 3/31/2024 | 10 | -31 | -15 | -14 | N/A |
| 12/31/2023 | 7 | -32 | -11 | -11 | N/A |
| 9/30/2023 | 5 | -27 | -7 | -6 | N/A |
| 6/30/2023 | 7 | -29 | -7 | -7 | N/A |
| 3/31/2023 | 9 | -21 | -8 | -7 | N/A |
| 12/31/2022 | 10 | -18 | -9 | -8 | N/A |
| 9/30/2022 | 24 | -21 | -11 | -9 | N/A |
| 6/30/2022 | 34 | -17 | -10 | -8 | N/A |
| 3/31/2022 | 41 | -17 | -9 | -7 | N/A |
| 12/31/2021 | 48 | -16 | -9 | -7 | N/A |
| 9/30/2021 | 45 | -13 | -7 | -5 | N/A |
| 6/30/2021 | 42 | -6 | -3 | -2 | N/A |
| 3/31/2021 | 38 | -3 | 0 | 1 | N/A |
| 12/31/2020 | 39 | -1 | 4 | 4 | N/A |
| 9/30/2020 | 40 | 1 | 4 | 5 | N/A |
| 12/31/2019 | 46 | 0 | 3 | 3 | N/A |
| 12/31/2018 | 45 | 0 | 3 | 4 | N/A |
| 12/31/2017 | 44 | 0 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6H90 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 6H90 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 6H90 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 6H90's revenue (49.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 6H90's revenue (49.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6H90's Return on Equity is forecast to be high in 3 years time